Therapeutic Approach to NAFLD-NASH
Nonalcoholic fatty liver disease (NAFLD) and its progressive form nonalcoholic steatohepatitis (NASH) are the hepatic expression of metabolic syndrome and may lead to serious injury to the liver resulting in cirrhosis and hepatocellular carcinoma (HCC). Despite its seriousness, there is no definite...
Guardado en:
| Autores principales: | , |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2022
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/84658 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares: Therapeutic Approach to NAFLD-NASH
- Regulation of Iron Metabolism in NAFLD/NASH
- Hepatic Lipid Homeostasis in NAFLD
- The Role of the Intestinal Microbiota in NAFLD Onset and Progression
- An Overview of Non-alcoholic Fatty Liver Diseases (NAFLD)
- Transcriptional Regulation by ERR and Its Role in NAFLD Pathogenesis
- Non-alcoholic-Related Fatty Liver Disease (NAFLD) as a Risk Factor for Atherosclerotic Cardiovascular Disease: The Hidden Link – ASCVD Risk Factors from NAFLD